End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
87.7 CNY | -2.32% | -7.47% | -30.34% |
Apr. 22 | Anhui Huaheng Biotechnology's Q1 Profit Jumps 7% | MT |
Apr. 22 | Anhui Huaheng Biotechnology's 2023 Profit Jumps 40% | MT |
Sales 2024 * | 3.17B 437M | Sales 2025 * | 4.02B 555M | Capitalization | 13.77B 1.9B |
---|---|---|---|---|---|
Net income 2024 * | 633M 87.34M | Net income 2025 * | 826M 114M | EV / Sales 2024 * | 4.56 x |
Net Debt 2024 * | 664M 91.61M | Net Debt 2025 * | 312M 43.11M | EV / Sales 2025 * | 3.5 x |
P/E ratio 2024 * |
21.8
x | P/E ratio 2025 * |
16.7
x | Employees | - |
Yield 2024 * |
1.39% | Yield 2025 * |
1.65% | Free-Float | 55.99% |
1 day | -2.32% | ||
1 week | -7.47% | ||
Current month | -7.47% | ||
1 month | -29.12% | ||
3 months | -27.27% | ||
6 months | -22.10% | ||
Current year | -30.34% |
Managers | Title | Age | Since |
---|---|---|---|
Geng Hua Guo
CEO | Chief Executive Officer | 60 | 05-04-12 |
Yi Fan
DFI | Director of Finance/CFO | 47 | 15-12-31 |
Xue Li Zhang
CTO | Chief Tech/Sci/R&D Officer | 43 | 13-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Qi Feng Zhang
BRD | Director/Board Member | 51 | 19-07-31 |
Lin Wu
BRD | Director/Board Member | 65 | 22-06-27 |
Geng Hua Guo
CEO | Chief Executive Officer | 60 | 05-04-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 32 M€ | +4.01% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 87.7 | -2.32% | 1,203,980 |
24-06-06 | 89.78 | -3.32% | 1,615,110 |
24-06-05 | 92.86 | +1.50% | 1,700,434 |
24-06-04 | 91.49 | -1.46% | 1,990,149 |
24-06-03 | 92.85 | -2.04% | 1,515,498 |
End-of-day quote Shanghai S.E., June 06, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.34% | 1.9B | |
-6.56% | 27.18B | |
+20.21% | 25.15B | |
+6.53% | 11.14B | |
+11.92% | 5.12B | |
+12.04% | 4.21B | |
-14.44% | 3.56B | |
+3.41% | 3.44B | |
-4.91% | 2.83B | |
+24.81% | 2.76B |
- Stock Market
- Equities
- 688639 Stock